ticagrelor api

Ticagrelor (274693-27-5) Ticagrelor is a novel platelet aggregation inhibitor and the world's first reversible, orally-administered P2Y12 adenosine diphosphate receptor antagonist. It is clinically used to reduce cardiovascular death and heart attack risk in patients with acute coronary syndrome. Product Specifications Product Name: Ticagrelor CAS No.: 274693-27-5 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C23H28F2N6O4S Molecular Weight: 522.57